| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3311382 | Hepatology Research | 2006 | 5 Pages |
Abstract
HBcrAg level at lamivudine cessation point might be useful as a prognostic predictor of response to lamivudine therapy cessation. The measurement of HBcrAg is a useful additional test for monitoring chronic HBV infection.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Noboru Shinkai, Yasuhiro Tanaka, Etsuro Orito, Kiyoaki Ito, Tomoyoshi Ohno, Noboru Hirashima, Izumi Hasegawa, Fuminaka Sugauchi, Ryuzo Ueda, Masashi Mizokami,